ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Harnessing The Power of Real-World Data In Clinical Trial Planning

  As the availability of RWD grows, it creates opportunities for sponsors to use true patient insights to support their clinical strategy and bring treatments to patients in need.

• Overcoming Participant Compliance Challenges In A Medical Device Study

  Uncover how Catalyst Clinical Research enhanced participant compliance and streamlined scheduling for a TENS device study using the TrialKit platform, with crucial support from CDS.

• Optimizing Data Capture From Protocol Design To Efficacy Endpoints

  The shift to digital trials favors the 11-point NRS over the traditional VAS to reduce data noise, improve elderly patient compliance, and ensure statistical power across mobile devices.

• How Technology Can Empower CAR T-Cell Therapy Clinical Trials

  Explore how innovative technologies are pushing advancements in CAR T-cell therapy, enhancing patient outcomes, and streamlining trial processes.

• Empowering Freenome: Large-Scale Data Quality And Compliance

  Delve into five ways this biotech company was able to successfully deliver data quality and compliance for large-scale trials while developing next-generation blood tests for early cancer detection.

• Training Program Reduces Placebo Effect By More Than 50% In ePRO Study

  Discover how an instruction program directly contributed to significantly lowering the placebo response rate in a phase III migraine CNS study.

• How Clinical Trial Complexity Impacts End Users

  This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.

• Is Your Clinical Supply Chain Fully Optimized?

  Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.

• Single-Arm Trials Use Real-World Evidence For Rare Disease Drug Development

  In rare disease product development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Gain insight into the regulatory considerations for single-arm trials.

• Redefining Evidence Generation In Modern Clinical Trials

  As trials continue to digitize, learn how connected sensors, COAs, PROs, and other forms of data will come together to form the evidence of tomorrow.